Capillary OGTT study for children and teens
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at using a finger-prick test instead of a standard blood draw for the oral glucose tolerance test (OGTT), which measures how your body handles sugar. It may help young people at risk for or with early type 1 diabetes avoid repeated needle sticks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be younger than 18 years old.
- You must be able to drink a sugary liquid within 10 minutes.
- You must be willing to have an oral glucose tolerance test (OGTT) or already be scheduled for one.
- If you have a higher risk of type 1 diabetes (positive for two or more islet autoantibodies), you may join a special group.
- You cannot take part if you have certain blood disorders like sickle cell disease, or if you already have diabetes and are on treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a continuous glucose monitor (a small sensor that tracks blood sugar levels) along with a special drink test to find early signs of diabetes. It may help people who are at risk or have early blood sugar problems get a clearer picture of their health.
This study tests using a continuous glucose monitor (CGM) in teenagers with type 1 diabetes in the Dominican Republic. The device tracks blood sugar levels around the clock to help manage their diabetes better. Participants will get support and education over about 15 months.
This study follows people of all ages who have a positive islet autoantibody test but no diabetes symptoms yet. It aims to track them over time to learn more about how type 1 diabetes develops, which may lead to better prevention and care.
This study tests a new extended-wear sensor that helps track glucose levels continuously. It is designed to see if a next-generation sensor is accurate and safe for people with diabetes.
This study uses artificial intelligence to better understand how type 2 diabetes progresses in young people. By wearing a continuous glucose monitor, you may help researchers find patterns that could improve future care.
This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.